Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation.
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Individuals with obstructive sleep apnea may have a new therapy to relieve their symptoms of fatigue, a study shows.
Researchers at the University of California, Davis and San Diego State University tested a medical device that applies a therapy called "continuous positive airway pressure" on 59 men and women suffering from the condition. All were in their late 40s and experienced at least 10 partial or complete pauses, or apneas, during an hour of sleep.
ResMed Inc. (NYSE:RMD) completed a two-for-one split of the company’s stock on August 30, doubling the number of its outstanding shares of common stock.
The San Diego-based sleep apnea device maker’s number of shares now stands at about 151.4 million, excluding those held as treasury stock, according to the company.